A detailed history of Werlinich Asset Management, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Werlinich Asset Management, LLC holds 3,755 shares of DGX stock, worth $514,772. This represents 0.32% of its overall portfolio holdings.

Number of Shares
3,755
Previous 3,905 3.84%
Holding current value
$514,772
Previous $512 Million 0.77%
% of portfolio
0.32%
Previous 0.33%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$125.91 - $144.34 $18,886 - $21,651
-150 Reduced 3.84%
3,755 $516 Million
Q1 2024

Apr 11, 2024

SELL
$123.78 - $142.11 $360,199 - $413,540
-2,910 Reduced 42.7%
3,905 $512 Million
Q4 2023

Jan 09, 2024

SELL
$120.62 - $141.12 $40,890 - $47,839
-339 Reduced 4.74%
6,815 $938 Million
Q3 2023

Nov 13, 2023

BUY
$121.86 - $144.92 $19,985 - $23,766
164 Added 2.35%
7,154 $872 Million
Q1 2023

Nov 13, 2023

BUY
$131.53 - $155.76 $1,315 - $1,557
10 Added 0.14%
6,990 $989 Million
Q4 2022

Nov 13, 2023

SELL
$123.31 - $157.26 $10,481 - $13,367
-85 Reduced 1.2%
6,980 $1.09 Billion
Q3 2022

Nov 13, 2023

SELL
$121.77 - $141.1 $12,177 - $14,110
-100 Reduced 1.4%
7,065 $867 Million
Q2 2022

Nov 13, 2023

SELL
$127.07 - $145.39 $66,711 - $76,329
-525 Reduced 6.83%
7,165 $953 Million
Q1 2022

Nov 13, 2023

SELL
$129.09 - $164.35 $31,627 - $40,265
-245 Reduced 3.09%
7,690 $1.05 Billion
Q3 2021

Nov 13, 2023

SELL
$132.95 - $158.0 $14,624 - $17,380
-110 Reduced 1.37%
7,935 $1.15 Billion
Q1 2021

Nov 13, 2023

BUY
$114.63 - $133.34 $922,198 - $1.07 Million
8,045 New
8,045 $1.03 Billion

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Werlinich Asset Management, LLC Portfolio

Follow Werlinich Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Werlinich Asset Management, LLC with notifications on news.